Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

Palantir Technologies (PLTR)

BUY

A fascinating business, though not in his wheelhouse. The next level of growth will come from companies that better manage data--and PLTR does this very well. This company will grow the commercial side of their business and do well. The high valuation is an issue for some investors. Like Shopify, this will likely grow into its high valuation.

BUY ON WEAKNESS
2020 IPOs cost too much, and are worth buying now that they are out of style and cheaper. He weakly recommended buying below $10, which happened in its first day of trading. This became a Reddit short, peaking at $45 in January stocking and has plunged to $24. It's a black box to really understand it. Buy below $20.
COMMENT
Risk is it becoming a momentum machines. Past performance draws in more dollars for a certain time. Mid-Feb and March saw a real sell-off. Be careful of expensive growth stocks. Not convinced they will start another major uptrend. There are more macro influences favouring reasonably priced value stocks. Not a lot of history and no earnings yet. Pure growth story. No metrics to value it on. Sentiment could sour and fall. Manage your risk and be prepared to sell.
BUY
Leadership in AI. Has attracted top talent. Price target is $33.
BUY

Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. Likes the long term prospects. A fairly unique company. In a tough environment for growth stocks. A buy with the recent weakness. Unlock Premium - Try 5i Free

DON'T BUY
A great growth company based on government contracts, but he doesn't know what those contracts are about. It's a black box, so he'll pass.
BUY
Companies will need to increase cybersecurity from attacks which are inevitable. Such stocks will benefit with a massive growth tailwind from this reality, including Palantir. PLTR has held well in recent weeks at support levels while similar SPAC names flagged.
DON'T BUY
The most controversial stock in this market, because Ark keeps buying. Last quarter was merely okay. Smart managers, but this stock is such a battleground.
TOP PICK

Some volatility. Leaders, along with c3.ai, in AI. Cutting edge in AI. Two platforms, one for government and one for commercial businesses. Helps people make better decisions, and it works. Buy 1/2 here around $26, and if you're lucky, another 1/2 around $22. Price target of $38. No dividend. (Analysts’ price target is $27.38)

DON'T BUY
Involved in big data. Excellent earnings, revenues projected to rise, stock price fell. How could this happen? Investors got giddy about the future, and the stock price got ahead of its fundamentals. Good company, lots of opportunity. Be aware that it has only the one customer in the US government and CIA.
BUY

Their IBM deal today is good; IBM is a fine partner, it's good to bring in artificial intelligence, and this deal verifies Palantir This is an "enthusiast" stock, which rises no matter what the quarterly report is, and PLTR has gone up a lot.

COMMENT
They do cybersecurity technology, but he doesn't know much about their contracts or clients. But cybersecurity is here to stay.
WATCH
Two analytic platforms for data to enable better decision making. Applies AI capabilities on top of the data. Now just shy of $30, his price target. A large market opportunity, so he remains bullish on it, but is watching it carefully.
DON'T BUY
Fairly new company in data analytics. Most of their business is with the US government. Could grow into a meaningful company, but the jury's out. A lot of companies are in this nascent area. Priced highly for assumed success, but it's less than guaranteed. He'd rather pay a little bit more for certainty.
TOP PICK
It recently went public in a direct listing. They do data analytics [in the area of intelligence and counter-terrorism] and are signing large contracts. They have strong customers and boasts high margins, because they don't customize software for each customer (which raises costs). The stock has done very well and is popping today. In five years, the stock should be much higher. (Analysts’ price target is $13.86)
Showing 46 to 60 of 60 entries